Calliditas Therapeutics
no clinically meaningful changes in blood pressure and body weight during treatment | Calliditas Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
June 2020
Slide
14 of 38
Related slides by other companies
Erasca
Investor Presentation
November 2023
eras significantly extends survival at clinically relevant exposures in an amplified and model treatment days | Erasca
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights